Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21

Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells ex vivo using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40...

Descripción completa

Detalles Bibliográficos
Autores principales: Kweon, SoonHo, Phan, Minh-Trang Thi, Chun, Sejong, Yu, HongBi, Kim, Jinho, Kim, Seokho, Lee, Jaemin, Ali, Alaa Kassim, Lee, Seung-Hwan, Kim, Sang-Ki, Doh, Junsang, Cho, Duck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491902/
https://www.ncbi.nlm.nih.gov/pubmed/31105701
http://dx.doi.org/10.3389/fimmu.2019.00879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491902/
https://www.ncbi.nlm.nih.gov/pubmed/31105701
http://dx.doi.org/10.3389/fimmu.2019.00879

Ejemplares similares